|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2004-8-12
|
|
pubmed:abstractText |
CD24 is expressed in hematological malignancies as well as in a large variety of solid tumors and is often associated with a more aggressive course of the disease. We aimed to evaluate CD24 protein expression in pancreatic adenocarcinomas and to correlate it to clinicopathological data including patient survival.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1424-3903
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2004 S. Karger AG, Basel and IAP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
454-60
|
|
pubmed:dateRevised |
2006-3-28
|
|
pubmed:meshHeading |
pubmed-meshheading:15256807-Adenocarcinoma,
pubmed-meshheading:15256807-Adult,
pubmed-meshheading:15256807-Aged,
pubmed-meshheading:15256807-Aged, 80 and over,
pubmed-meshheading:15256807-Antigens, CD,
pubmed-meshheading:15256807-Antigens, CD24,
pubmed-meshheading:15256807-Female,
pubmed-meshheading:15256807-Humans,
pubmed-meshheading:15256807-Immunohistochemistry,
pubmed-meshheading:15256807-Male,
pubmed-meshheading:15256807-Membrane Glycoproteins,
pubmed-meshheading:15256807-Middle Aged,
pubmed-meshheading:15256807-Pancreas,
pubmed-meshheading:15256807-Pancreatic Neoplasms,
pubmed-meshheading:15256807-Prognosis,
pubmed-meshheading:15256807-Staining and Labeling,
pubmed-meshheading:15256807-Survival Analysis,
pubmed-meshheading:15256807-Tumor Markers, Biological
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades.
|
|
pubmed:affiliation |
Institute of Pathology, Charité University Hospital, Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article
|
